Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Woodruff

Showing results (301-310 of 443) with videos related to

Pageof 45
Sort By:
Inflammation|June 14, 2001
Species dependence for binding of small molecule agonist and antagonists to the C5a receptor on polymorphonuclear leukocytesT M Woodruff, A J Strachan, S D Sanderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for managementM J Heslin, J J Lewis, E Nadler, et al.
Journal of Neurochemistry|February 6, 2010
Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's diseaseRahasson R Ager, Maria I Fonseca, Shu-Hui Chu, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 18, 2010
The role of the ribosomal protein S19 C-terminus in Gi protein-dependent alternative activation of p38 MAP kinase via the C5a receptor in HMC-1 cellsHiroshi Nishiura, Kazutaka Tokita, Ying Li, et al.
International Immunopharmacology|June 20, 2006
Complement inhibitors selectively attenuate injury following administration of cobra venom factor to ratsLavinia M Proctor, Anna J Strachan, Trent M Woodruff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2008
The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosisTrent M Woodruff, Kerina J Costantini, James W Crane, et al.
Molecular Neurobiology|January 22, 2024
A Panel of miRNA Biomarkers Common to Serum and Brain-Derived Extracellular Vesicles Identified in Mouse Model of Amyotrophic Lateral SclerosisNatasha Vassileff, Jereme G Spiers, John D Lee, et al.
Frontiers in Immunology|April 21, 2023
<i>In vitro</i> evaluation of iron oxide nanoparticle-induced thromboinflammatory response using a combined human whole blood and endothelial cell modelAlexandra Gerogianni, Melissa Bal, Camilla Mohlin, et al.
The American Journal of Surgical Pathology|December 10, 2008
Malignant peripheral nerve sheath tumors of cranial nerves and intracranial contents: a clinicopathologic study of 17 casesBernd W Scheithauer, Sibel Erdogan, Fausto J Rodriguez, et al.
Journal of Cardiovascular Pharmacology|July 15, 2011
Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive ratsAbishek Iyer, Trent M Woodruff, Mike C L Wu, et al.
Pageof 45

Showing results (301-310 of 443) with videos related to

Sort By:
Pageof 45
Inflammation|June 14, 2001
Species dependence for binding of small molecule agonist and antagonists to the C5a receptor on polymorphonuclear leukocytesT M Woodruff, A J Strachan, S D Sanderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for managementM J Heslin, J J Lewis, E Nadler, et al.
Journal of Neurochemistry|February 6, 2010
Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's diseaseRahasson R Ager, Maria I Fonseca, Shu-Hui Chu, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 18, 2010
The role of the ribosomal protein S19 C-terminus in Gi protein-dependent alternative activation of p38 MAP kinase via the C5a receptor in HMC-1 cellsHiroshi Nishiura, Kazutaka Tokita, Ying Li, et al.
International Immunopharmacology|June 20, 2006
Complement inhibitors selectively attenuate injury following administration of cobra venom factor to ratsLavinia M Proctor, Anna J Strachan, Trent M Woodruff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2008
The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosisTrent M Woodruff, Kerina J Costantini, James W Crane, et al.
Molecular Neurobiology|January 22, 2024
A Panel of miRNA Biomarkers Common to Serum and Brain-Derived Extracellular Vesicles Identified in Mouse Model of Amyotrophic Lateral SclerosisNatasha Vassileff, Jereme G Spiers, John D Lee, et al.
Frontiers in Immunology|April 21, 2023
<i>In vitro</i> evaluation of iron oxide nanoparticle-induced thromboinflammatory response using a combined human whole blood and endothelial cell modelAlexandra Gerogianni, Melissa Bal, Camilla Mohlin, et al.
The American Journal of Surgical Pathology|December 10, 2008
Malignant peripheral nerve sheath tumors of cranial nerves and intracranial contents: a clinicopathologic study of 17 casesBernd W Scheithauer, Sibel Erdogan, Fausto J Rodriguez, et al.
Journal of Cardiovascular Pharmacology|July 15, 2011
Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive ratsAbishek Iyer, Trent M Woodruff, Mike C L Wu, et al.
Pageof 45